PulseAGGREGATOR

Home Feed Stories Sources Features

PulseAGGREGATOR

Gathering headlines…

Pulse Aggregator

Your news command center for 10,000+ sources. Search, filter, and set alerts — then cut through the noise with bias analysis, story clustering, and blindspot detection.

PR Newswire

prCenter

1d ago

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the UStranslating…

MUMBAI, India and WARREN, N.J., Sept. 3, 2026 /PRNewswire/ -- Invagen Pharmaceuticals Inc, a wholly owned subsidiary of Cipla Limited (BSE: 500087) (NSE: CIPLA) today announced that it has entered into a strategic partnership with Qilu Pharmaceutical Co., Ltd. (hereinafter…

Factuality

70/100

Political Bias

Center

Ownership

Cision

Country

USA

Region

North America

Language

English

Keywords#Cipla#Qilu Pharmaceutical#Partnership#Announces#Announces Exclusive

Read Original ↗ Article view

Comments

Loading comments…

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US | Pulse Aggregator